Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07301320) titled 'Epetraborole in Patients With Mycobacterium Abscessus Lung Disease' on Dec. 22, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Kevin Winthrop
Condition:
Mycobacterium Abscessus Infection
Intervention:
Drug: Epetraborole
Drug: Epetraborole
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: January 2026
Target Sample Size: 84
Countries of Recruitment:
United States
To know mor...